Laser or Anti-VEGF Injections for ROP: Which Is Right?

When a premature baby needs treatment for retinopathy of prematurity (ROP), the goal is to prevent severe, permanent vision loss ^[1]. This diagnosis is not your fault, and treatment is time-sensitive, so it is important not to delay while weighing options ^[1]. To decide between the two main treatments—laser therapy or anti-VEGF eye injections—the ophthalmology team will look closely at your baby’s eyes to determine the Zone, Stage, and presence of Plus disease ^[2][1]. They will also consider your baby’s overall medical stability ^[3].

Understanding the Doctor’s Assessment

To understand the treatment choice, it helps to know how doctors describe ROP:

• Zone: How far the abnormal blood vessels are from the center of the retina (the light-sensing tissue at the back of the eye) ^[2]. Zone I is the deep center, Zone II is further out, and Zone III is the far outer edge ^[2].
• Stage: How severely abnormal the blood vessel growth is ^[2].
• Plus disease: When the blood vessels become enlarged and twisted, indicating the disease is active and dangerous ^[2].
• Aggressive ROP: A rare, fast-moving form of the disease that requires urgent treatment ^[4].

Laser Treatment: A Durable Option

Laser photocoagulation uses small laser burns to treat the avascular retina—the outer edges of the retina where normal blood vessels haven’t grown ^[5]. This stops the eye from producing the chemical signals that cause damaging vessels to grow ^[5].

Benefits:

• Often a durable treatment: Laser is generally a one-time procedure with a lower risk of the disease reactivating (coming back) later compared to injections ^[6][3].
• Fewer late recurrences: Because it permanently alters the edge of the retina, babies treated with laser usually do not require the same prolonged, intense monitoring for late recurrence that injections require ^[3].

Considerations:

• Changes to side vision: The laser permanently treats the outer retina, which reduces the baby’s peripheral (side) vision ^[5]. However, untreated ROP itself can cause total vision loss ^[1].
• Refractive errors: Babies treated with laser have a significantly higher risk of developing severe myopia (near-sightedness) as they grow ^[7].
• Anesthesia needs: The procedure takes time and often requires general anesthesia or deep sedation, and sometimes breathing support, which the medical team must carefully weigh against your baby’s respiratory health ^[8].
• Follow-up is still required: While less intense than injection follow-up, your baby will still need an early post-treatment exam and long-term eye exams to monitor for glasses, crossed eyes, or lazy eye as they grow ^[9].

Anti-VEGF Injections: Preserving the Retina

Anti-VEGF medications (such as bevacizumab, ranibizumab, or aflibercept) are injected directly into the eye ^[5]. These drugs block VEGF (Vascular Endothelial Growth Factor), a protein responsible for abnormal vessel growth ^[5].

Benefits:

• May preserve more vision: Because it doesn’t burn the tissue, the medication can allow normal blood vessels to continue growing, which may preserve more of the baby’s side vision ^[5].
• Less severe near-sightedness: Injections are associated with a lower risk of severe myopia compared to laser treatment ^[7].
• Avoids general anesthesia: The injections are quick and usually performed with numbing eye drops, comfort measures, and cardiorespiratory monitoring, rather than deep general anesthesia ^[8].
• Rapid response: Injections can quickly shut down active, aggressive posterior ROP ^[8].

Considerations:

• High risk of silent late recurrence: As the medication wears off over weeks or months, the ROP can reactivate ^[10][11]. This recurrence is silent—you will not see symptoms—so missing an appointment can threaten your baby’s vision ^[9].
• Intense, individualized follow-up: Babies need strict, frequent eye exams for many months until the retina finishes vascularizing (growing vessels) ^[9][12]. If the vessels never fully finish growing, the baby might eventually need laser treatment anyway ^[11].
• Systemic exposure: The medication can enter the baby’s bloodstream and lower VEGF levels in the rest of the body ^[13]. Different drugs have different exposure levels, and some are used off-label ^[13]. While some studies show no obvious harm, the long-term safety of this exposure on a premature baby’s developing brain and organs is not fully proven ^[13][14].

How the Care Team Makes a Recommendation

Treatment choice is highly individualized ^[3]. It is not based on Zone alone, but rather a combination of the Zone, Stage, Plus disease, and your baby’s overall medical stability ^[3][1].

• For Zone I or Aggressive ROP, doctors often lean toward injections because the disease is deep in the eye ^[15]. Using a laser here could require treating a large amount of retina, whereas injections can act quickly and allow the retina to keep developing ^[15].
• For Zone II disease, laser is often recommended because less of the peripheral retina needs to be treated, making the side-vision loss less significant while providing a highly reliable, durable result ^[15][16].

Logistics and Access: Reliable follow-up is a critical safety issue, especially for injections ^[3]. If you have concerns about travel distance, reliable transportation, or taking time off work for months of frequent visits, tell your care team early ^[3]. They can connect you with a NICU social worker to arrange transport, lodging, or a shared-care plan to ensure your baby gets the necessary follow-up without compromising their treatment choice ^[3].